Professional Edition

Doctor's Guide to Medical Conferences & Meetings
What's NewMissionSponsorsWarningSearchSite Map



Subject
Diltiazem the Drug of Choice for Patients with Non-Q Wave Myocardial Infarction
New Insights Into The Pathogenesis And Management Of Coronary Artery Disease
Drug Reduces Risk of Stroke for Hypertensive Patients
Presentation of the Verapamil in Hypertension and Atherosclerosis Study
Atrial Fibrillation: The Clinically Relevant Trials and Results
Clinical Trials and Their Implications in the Management of Acute Myocardial Infarction
The Strengths and Limitations of Large Multicentre Trials
Heart Failure Trials: Extracting the Clinically Relevant Information
Long-term Management During the Postinfarction Period Based on Trial Results
The Trials Guiding Current Approaches to Ventricular Arrhythmias and Sudden Death
Propafenone is Effective and Safe for Conversion and Suppression of SVAs
Reassessing Calcium Channel Blockers
Verapamil and Heart Transplantation
Verapamil Helps to Prevent Reinfarction
Expanding Role of Regional Anesthesia
Further Positive Findings From 4S Trial
AZT/3TC combination is promising in treating HIV infection
Lipid-Lowering Drug Reduces Mortality





HomeWhat's NewSponsorsWarningSearchSite Map

Any question regarding a medical diagnosis, treatment, referral, drug availability or
pricing should be directed to either a licenced physician or to the product's manufacturer.


If you have any technical questions or other concerns about
this site, feel free to contact us at webmaster@pslgroup.com.


All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.